Connect Biopharma is trading at $0.92, up 5.76% in live trading on October 12, 2026; the reason for the gain remains unclear.
- No clear company-specific catalyst was found. The latest located announcement was September 30 preliminary Phase 2 COPD data; its source does not link it to the move and lists no October 12 announcement.
- Broader indexes were nearly flat, but available context does not establish a market-wide reason; trading volume was unavailable in the provided price context.